Stage IV Renal Cell Cancer AJCC v7
Showing 1 - 15 of 15
Advanced Malignant Solid Tumor, Stage III Cutaneous Melanoma AJCC v7, Stage III Prostate Cancer AJCC v7 Trial in New Brunswick
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +9 more
- Akt Inhibitor MK2206
- Hydroxychloroquine
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 25, 2023
Advanced Clear Cell Renal Cell Carcinoma, Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant, Infiltrating Bladder
Active, not recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +35 more
- Cabozantinib S-malate
- +2 more
-
Duarte, California
- +7 more
Jan 3, 2023
Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States
Active, not recruiting
- Clear Cell Renal Cell Carcinoma
- +3 more
- Aldesleukin
- +6 more
-
Los Angeles, California
- +3 more
Nov 16, 2022
Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in Houston (other,
Completed
- Clear Cell Renal Cell Carcinoma
- +3 more
- Laboratory Biomarker Analysis
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 30, 2022
Locally Advanced Papillary Renal Cell Carcinoma, Metastatic Papillary Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7
Active, not recruiting
- Locally Advanced Papillary Renal Cell Carcinoma
- +6 more
- Cabozantinib S-malate
- +3 more
-
Anchorage, Alaska
- +596 more
Aug 2, 2022
Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Cancer, Stage IV Renal Cell Cancer AJCC v7 Trial in Houston (procedure,
Completed
- Clear Cell Renal Cell Carcinoma
- +2 more
- Cryosurgery
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 6, 2022
Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial in United
Terminated
- Clear Cell Renal Cell Carcinoma
- +4 more
- Ascorbic Acid
- Pazopanib Hydrochloride
-
Peoria, Illinois
- +4 more
Mar 18, 2022
Stage IV Renal Cell Cancer AJCC V7 Trial in Calgary, Toronto (Pembrolizumab, Stereotactic Body Radiation Therapy)
Completed
- Stage IV Renal Cell Cancer AJCC V7
- Pembrolizumab
- Stereotactic Body Radiation Therapy
-
Calgary, Alberta, Canada
- +2 more
Aug 26, 2021
Recurrent Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7, Stage IV Renal Cell Cancer AJCC v7 Trial in Bronx, New York
Completed
- Recurrent Renal Cell Carcinoma
- +2 more
- Capecitabine
- +2 more
-
Bronx, New York
- +3 more
Mar 17, 2021
Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States
Completed
- Clear Cell Renal Cell Carcinoma
- +3 more
- Cabozantinib S-malate
- +2 more
-
Mobile, Alabama
- +487 more
Jan 28, 2021
Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Stage I Renal Cell Cancer AJCC v6 and v7 Trial in New York
Terminated
- Clear Cell Renal Cell Carcinoma
- +5 more
- Metastasectomy
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 22, 2020
Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage IV Renal Cell Cancer AJCC v7 Trial in Houston (biological,
Unknown status
- Clear Cell Renal Cell Carcinoma
- +2 more
- Bevacizumab
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Mar 19, 2020
Metastatic Kidney Carcinoma, Recurrent Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States (Akt
Terminated
- Metastatic Kidney Carcinoma
- +3 more
- Akt Inhibitor MK2206
- +2 more
-
Beverly Hills, California
- +7 more
Sep 25, 2019
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States
Terminated
- Clear Cell Renal Cell Carcinoma
- +3 more
- Bevacizumab
- +3 more
-
Scottsdale, Arizona
- +523 more
Mar 5, 2019
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v7 Trial in Peru, United States
Completed
- Clear Cell Renal Cell Carcinoma
- +2 more
- Bevacizumab
- +4 more
-
Birmingham, Alabama
- +558 more
Oct 15, 2018